CCDC40 p.Thr112Ala

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_017950.4(CCDC40):​c.334A>G​(p.Thr112Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00397 in 1,614,104 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T112M) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0041 ( 16 hom. )

Consequence

CCDC40
NM_017950.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.981

Publications

6 publications found
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCDC40 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autoimmune disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_017950.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0055594146).
BP6
Variant 17-80040052-A-G is Benign according to our data. Variant chr17-80040052-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 166808.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00249 (379/152342) while in subpopulation NFE AF = 0.00406 (276/68026). AF 95% confidence interval is 0.00366. There are 0 homozygotes in GnomAd4. There are 177 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 16 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017950.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCDC40
NM_017950.4
MANE Select
c.334A>Gp.Thr112Ala
missense
Exon 3 of 20NP_060420.2
CCDC40
NM_001243342.2
c.334A>Gp.Thr112Ala
missense
Exon 3 of 18NP_001230271.1Q4G0X9-2
CCDC40
NM_001330508.2
c.334A>Gp.Thr112Ala
missense
Exon 3 of 11NP_001317437.1Q4G0X9-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCDC40
ENST00000397545.9
TSL:5 MANE Select
c.334A>Gp.Thr112Ala
missense
Exon 3 of 20ENSP00000380679.4Q4G0X9-1
CCDC40
ENST00000374876.4
TSL:1
c.334A>Gp.Thr112Ala
missense
Exon 3 of 9ENSP00000364010.4Q4G0X9-5
CCDC40
ENST00000897784.1
c.334A>Gp.Thr112Ala
missense
Exon 3 of 21ENSP00000567843.1

Frequencies

GnomAD3 genomes
AF:
0.00248
AC:
378
AN:
152224
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000892
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00249
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00406
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00236
AC:
585
AN:
248092
AF XY:
0.00250
show subpopulations
Gnomad AFR exome
AF:
0.000387
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000510
Gnomad NFE exome
AF:
0.00381
Gnomad OTH exome
AF:
0.00281
GnomAD4 exome
AF:
0.00413
AC:
6036
AN:
1461762
Hom.:
16
Cov.:
33
AF XY:
0.00399
AC XY:
2900
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33474
American (AMR)
AF:
0.00161
AC:
72
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00249
AC:
215
AN:
86258
European-Finnish (FIN)
AF:
0.000805
AC:
43
AN:
53418
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00487
AC:
5416
AN:
1111892
Other (OTH)
AF:
0.00432
AC:
261
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
304
609
913
1218
1522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
214
428
642
856
1070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00249
AC:
379
AN:
152342
Hom.:
0
Cov.:
32
AF XY:
0.00238
AC XY:
177
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.000890
AC:
37
AN:
41584
American (AMR)
AF:
0.00248
AC:
38
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4832
European-Finnish (FIN)
AF:
0.000941
AC:
10
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00406
AC:
276
AN:
68026
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00346
Hom.:
0
Bravo
AF:
0.00238
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00420
EpiControl
AF:
0.00302

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
2
Primary ciliary dyskinesia (2)
-
1
1
Primary ciliary dyskinesia 15 (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.29
DANN
Benign
0.55
DEOGEN2
Benign
0.027
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0063
N
LIST_S2
Benign
0.50
T
M_CAP
Benign
0.0015
T
MetaRNN
Benign
0.0056
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N
PhyloP100
-0.98
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.45
N
REVEL
Benign
0.017
Sift
Benign
0.68
T
Sift4G
Benign
0.89
T
Varity_R
0.019
gMVP
0.12
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs201709592;
hg19: chr17-78013851;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.